| Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation SA Yuzwa, X Shan, MS Macauley, T Clark, Y Skorobogatko, K Vosseller, ... Nature chemical biology 8 (4), 393-399, 2012 | 606 | 2012 |
| TBK1 at the crossroads of inflammation and energy homeostasis in adipose tissue P Zhao, X Sun, SM Reilly, M Uhm, Z Liao, Y Skorobogatko, AR Saltiel Cell 172 (4), 731-743. e12, 2018 | 219 | 2018 |
| Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody SA Yuzwa, AK Yadav, Y Skorobogatko, T Clark, K Vosseller, DJ Vocadlo Amino acids 40, 857-868, 2011 | 148 | 2011 |
| In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation MK Tallent, N Varghis, Y Skorobogatko, L Hernandez-Cuebas, K Whelan, ... Journal of biological chemistry 284 (1), 174-181, 2009 | 148 | 2009 |
| Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling C Tarn, E Merkel, AA Canutescu, W Shen, Y Skorobogatko, MJ Heslin, ... Clinical Cancer Research 11 (10), 3668-3677, 2005 | 142 | 2005 |
| Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms C Tarn, YV Skorobogatko, T Taguchi, B Eisenberg, M von Mehren, ... Cancer research 66 (10), 5477-5486, 2006 | 95 | 2006 |
| Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor L Rink, Y Skorobogatko, AV Kossenkov, MG Belinsky, T Pajak, ... Molecular cancer therapeutics 8 (8), 2172-2182, 2009 | 67 | 2009 |
| Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry YV Skorobogatko, J Deuso, J Adolf-Bergfoyle, MG Nowak, Y Gong, ... Amino acids 40, 765-779, 2011 | 66 | 2011 |
| O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles Y Skorobogatko, A Landicho, RJ Chalkley, AV Kossenkov, G Gallo, ... Journal of Biological Chemistry 289 (6), 3602-3612, 2014 | 65 | 2014 |
| High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors MG Belinsky, YV Skorobogatko, L Rink, J Pei, KQ Cai, LA Vanderveer, ... Genes, Chromosomes and Cancer 48 (10), 886-896, 2009 | 52 | 2009 |
| RalA controls glucose homeostasis by regulating glucose uptake in brown fat Y Skorobogatko, M Dragan, C Cordon, SM Reilly, CW Hung, W Xia, ... Proceedings of the National Academy of Sciences 115 (30), 7819-7824, 2018 | 49 | 2018 |
| Bi-allelic variants in RALGAPA1 cause profound neurodevelopmental disability, muscular hypotonia, infantile spasms, and feeding abnormalities M Wagner, Y Skorobogatko, B Pode-Shakked, CM Powell, B Alhaddad, ... The American Journal of Human Genetics 106 (2), 246-255, 2020 | 20 | 2020 |
| Swi1 associates with chromatin through the DDT domain and recruits Swi3 to preserve genomic integrity C Noguchi, JB Rapp, YV Skorobogatko, LD Bailey, E Noguchi Public Library of Science 7 (8), e43988, 2012 | 19 | 2012 |
| Tandem lectin weak affinity chromatography for glycoprotein enrichment ZY Ma, Y Skorobogatko, K Vosseller Mass Spectrometry of Glycoproteins: Methods and Protocols, 21-31, 2013 | 13 | 2013 |
| Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and … AK Godwin, B Eisenberg, Y Skorobogatko, L Rink, A Kossenkov, MF Ochs US Patent App. 14/467,984, 2015 | 10 | 2015 |
| Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and … AK Godwin, B Eisenberg, Y Skorobogatko, L Rink, A Kossenkov, MF Ochs US Patent App. 13/265,686, 2013 | 1 | 2013 |
| 1674-P: Increased Glucose Uptake in Brown Fat Promotes Energy Expenditure F REZAYAT, JA RESNICK, IM FARAH, Y SKOROBOGATKO, A SALTIEL Diabetes 72 (Supplement_1), 2023 | | 2023 |
| Post-translational Modification of Brain Proteins with O-Linked N-Acetyl-D-Glucosamine Y Skorobogatko Drexel University, 2013 | | 2013 |
| Chemical Inhibition of O-GlcNAc Processing: Role of O-GlcNAc in Tau-Driven Neurodegeneration S Yuzwa, X Shan, M Macauley, T Clark, Y Skorobogatko, K Vosseller, ... GLYCOBIOLOGY 21 (11), 1528-1528, 2011 | | 2011 |
| Spotlight on Clinical Response SE Woodman, JC Trent, K Stemke-Hale, AJ Lazar, S Pricl, GM Pavan, ... Mol Cancer Ther 8 (8), 2009 | | 2009 |
